PA
BVS icon

Parallel Advisors’s Bioventus BVS Stock Holding History

Parallel Advisors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96K Sell
313
-1,690
-84% -$16.1K ﹤0.01% 3407
2026
Q1 		$18.3K Buy
+2,003
New +$16.8K ﹤0.01% 2521
2025
Q2 		– Sell
-36
Closed -$329 – 3563
2025
Q1 		$329 Buy
+36
New +$360 ﹤0.01% 3310
2022
Q3 		– Sell
-33
Closed – – 3162
2022
Q2 		$0 Buy
+33
New +$337 ﹤0.01% 3020
2022
Q1 		– Sell
-21
Closed – – 2992
2021
Q4 		$0 Sell
21
-312
-94% -$4.43K ﹤0.01% 3098
2021
Q3 		$5K Buy
+333
New +$5.12K ﹤0.01% 2334

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parallel Advisors's BVS Position: Q2 2026 in Review

Parallel Advisors reduced its Bioventus (BVS) stake by 84% in Q2 2026, selling an estimated $16.1K and leaving 313 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #3407.

Parallel Advisors first reported a position in BVS in Q3 2021 and has held it in 6 quarters since. The position peaked at $18.3K in Q1 2026. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Parallel Advisors held 313 shares of Bioventus worth $2.96K as of Q2 2026.
  • Parallel Advisors sold 1,690 Bioventus shares in Q2 2026, an estimated $16.1K.
  • Bioventus made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3407 holding.
  • Parallel Advisors first reported a position in Bioventus in Q3 2021 and has held it in 6 quarters since.
  • Parallel Advisors's Bioventus position peaked at $18.3K in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.